Mounjaro®
Starting from £179.99/mo
Start journey Learn moreStomach cramping on Wegovy is common, particularly in the early weeks of treatment or after a dose increase — and it almost always has a straightforward cause that can be managed. It is not a sign the medicine is failing, and it rarely means you need to stop. Wegovy (semaglutide) is a prescription-only GLP-1 medicine licensed for weight management in UK adults, and like all medicines it requires clinical assessment before a prescriber can determine whether it is right for you.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
This is the belief that sends a lot of people to search engines in a hurry, and it is understandable. Cramping is uncomfortable and feels like a warning. The reality is that it is a predictable consequence of how semaglutide works, not evidence of a problem with your pen, your prescription or your body's response to the medicine.
Semaglutide activates GLP-1 receptors throughout the gut. One effect is slowed gastric emptying — food leaves the stomach more gradually, which is part of why appetite falls. But a slower, fuller gastrointestinal tract is also one that can produce gas, pressure and cramping, especially when you eat at the same pace and portion size you used before starting treatment. The gut is doing something different; it takes time to recalibrate.
The NHS semaglutide page lists stomach pain and cramping among the known side effects of the medicine, not as a rare complication but as part of the expected GI profile. Knowing that puts it in its proper place: something to manage, not something to panic about.
If you have been reading around cramping and semaglutide more broadly, you will find this pattern holds across the drug class.
Most cramping settles. Some does not, and a smaller number of situations need prompt attention rather than watchful waiting.
Cramping that is severe, does not ease within a few hours, and radiates toward your back (with or without vomiting) is the pattern associated with acute pancreatitis. In January 2026 the MHRA issued a Drug Safety Update specifically highlighting acute pancreatitis as an infrequent but serious risk with GLP-1 medicines; the guidance is explicit that patients should seek urgent medical help for that symptom pattern. You can report suspected side effects directly to the MHRA via the Yellow Card scheme.
Cramping accompanied by significant diarrhoea and vomiting at the same time raises a separate concern: dehydration. Losing fluids quickly on a GLP-1 medicine can strain kidney function, so if you cannot keep water down for more than a few hours, contact a healthcare professional the same day rather than waiting it out.
There is also a distinct pattern some people describe that feels more like rapid gut transit after eating (sometimes called dumping on Wegovy) which is different from cramping caused by gas and distension and worth understanding separately.
Gallbladder symptoms (pain in the upper right abdomen, particularly after fatty meals) are also listed in the semaglutide safety information. If cramping is consistently worse after rich or fatty food and located to the upper right, mention it to your prescriber.
The most consistent advice from clinical practice is about how you eat rather than what you eat, at least to begin with.
Eating more slowly gives a stomach that empties more gradually the time it needs. Smaller meals, spread across the day, reduce the volume the gut has to work with at any one point. Fizzy drinks and foods that produce gas in the gut (certain brassicas, pulses, high-fructose products) can amplify bloating and cramping when gastric emptying is slowed, so dialling them back temporarily is worth trying.
Staying well hydrated matters too. Semaglutide reduces thirst alongside appetite in some people, and mild dehydration tightens the gut and worsens cramping. Aim for regular small amounts of water across the day rather than large amounts infrequently.
Stomach cramping on Wegovy often peaks at a new dose and improves substantially within two to three weeks as the GI system adjusts. If it does not, that is exactly the kind of thing to raise at your next prescriber review, not something to push through indefinitely. A prescriber can consider whether the titration pace suits you. If questions about cost or how the service works are on your mind too, the Wegovy pricing page lays out what is included in a private prescription at a regulated pharmacy.
Clinicians want to know the character of the cramping: where it sits, how long it lasts, whether it comes on during or after eating, and whether anything makes it better or worse. Keeping a simple note (date, timing, severity out of ten, what you had eaten) for a week before your review gives a prescriber something specific to work with.
If your treatment was arranged through an online pharmacy, this is exactly what aftercare support is there for. Our prescribers at nume review every repeat order clinically; they can also be reached between orders if a side effect like this is affecting your daily life. You do not have to wait for a scheduled review to ask.
The wider picture of how semaglutide affects the body, including the full side-effect profile, is set out on our semaglutide information page. And if you are still deciding whether Wegovy is the right option for you, a free consultation with our clinical team is the natural starting point, no commitment required, reviewed by a GPhC-registered prescriber the same day.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.